We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A new Medicaid rule being proposed by the Centers for Medicare & Medicaid Services (CMS) could lower generic drug sales and should be amended to reflect actual acquisition costs for retailers that fill prescriptions with generic drugs, a pharmacist group said.
Two companies announced they are taking steps to provide easier access to needed medications in developing countries, while an advocacy group claimed a third company is preventing access to HIV medication through an overload of patents.
Amgen is facing more bad news regarding possible off-label uses of its drug Aranesp after independent study results pointed to adverse outcomes for a certain class of cancer patients prescribed the drug.